Altrius Capital Management’s AstraZeneca AZN Stock Holding History

Altrius Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Buy	57,997 +2,469	+4%	+$464K	2.09%	7
2026 Q1	$11M	Sell	55,528 -2,004	-3%	-$386K	2.18%	5
2025 Q4	$10.6M	Sell	57,532 -2,248	-4%	-$394K	2.24%	3
2025 Q3	$9.17M	Buy	59,780 +769	+1%	+$116K	2.09%	7
2025 Q2	$8.25M	Buy	59,011 +184	+0.3%	+$25.8K	1.93%	19
2025 Q1	$8.65M	Buy	58,827 +1,250	+2%	+$181K	2.1%	9
2024 Q4	$7.54M	Buy	57,577 +3,182	+6%	+$445K	2.03%	11
2024 Q3	$8.48M	Sell	54,395 -1,712	-3%	-$276K	2.12%	9
2024 Q2	$8.75M	Sell	56,107 -263	-0.5%	-$39.6K	2.3%	2
2024 Q1	$7.64M	Buy	56,370 +6,511	+13%	+$862K	1.93%	15
2023 Q4	$6.72M	Buy	49,859 +817	+2%	+$106K	1.87%	15
2023 Q3	$6.64M	Buy	49,042 +613	+1%	+$83.7K	1.97%	13
2023 Q2	$6.93M	Sell	48,429 -153	-0.3%	-$22.5K	2.05%	11
2023 Q1	$6.74M	Buy	48,582 +902	+2%	+$121K	2.06%	12
2022 Q4	$6.47M	Buy	47,680 +710	+2%	+$89K	2.03%	7
2022 Q3	$5.15M	Buy	46,970 +7,074	+18%	+$897K	1.96%	3
2022 Q2	$5.27M	Buy	+39,896	New	+$5.23M	1.71%	6

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Altrius Capital Management's AZN Position: Q2 2026 in Review

Altrius Capital Management increased its AstraZeneca (AZN) stake by 4.4% in Q2 2026, buying an estimated $464K and bringing the position to 57,997 shares worth $11M. The position accounts for 2.09% of the portfolio, ranked #7.

Altrius Capital Management first reported a position in AZN in Q2 2022 and has held it in 17 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Altrius Capital Management held 57,997 shares of AstraZeneca worth $11M as of Q2 2026.
Altrius Capital Management bought 2,469 AstraZeneca shares in Q2 2026, an estimated $464K.
AstraZeneca made up 2.09% of Altrius Capital Management's portfolio in Q2 2026, its #7 holding.
Altrius Capital Management first reported a position in AstraZeneca in Q2 2022 and has held it in 17 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Altrius Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.